BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27350406)

  • 1. Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis.
    Xiong C; Liu H; Chen Z; Yu Y; Liang C
    Eur J Intern Med; 2016 Sep; 33():102-7. PubMed ID: 27350406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
    Pu Z; Wang Q; Xie H; Wang G; Hao H
    Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis.
    Ma C; Lu B; Sun E
    Postgrad Med J; 2017 Apr; 93(1098):186-192. PubMed ID: 27489375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
    Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
    Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
    Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis.
    Du Y; Long Q; Guan B; Mu L
    Dis Markers; 2015; 2015():568980. PubMed ID: 26526157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
    Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
    PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
    Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
    Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of survivin in patients with glioma.
    Zhang S; Zhang C; Song Y; Zhang J; Xu J
    Medicine (Baltimore); 2018 Apr; 97(17):e0571. PubMed ID: 29703049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
    Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
    PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.
    Zhang L; Zha Z; Qu W; Zhao H; Yuan J; Feng Y; Wu B
    BMC Cancer; 2018 Sep; 18(1):870. PubMed ID: 30176824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma.
    Liu JL; Zhang XJ; Zhang Z; Zhang AH; Wang W; Dong JH
    PLoS One; 2013; 8(12):e83350. PubMed ID: 24386184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.
    Liu JL; Gao W; Kang QM; Zhang XJ; Yang SG
    PLoS One; 2013; 8(8):e71930. PubMed ID: 23936532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
    Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis.
    Cheng KY; Wang ZL; Gu QY; Hao M
    PLoS One; 2016; 11(10):e0165117. PubMed ID: 27764228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
    Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
    Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of survivin expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Tumour Biol; 2013 Aug; 34(4):2053-62. PubMed ID: 23690235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
    Kim SI; Kim SJ; Kim SJ; Cho DS
    Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.